Kanjana S. Perera, MBBS; Danielle de Sa Boasquevisque, MD; Purnima Rao-Melacini, MSc; et al.
JAMA Neurol. 2022;79(5):450-458. doi:10.1001/jamaneurol.2022.0048
This cohort study evaluates rates of and factors associated with recurrent ischemic stroke and death as well as new-onset atrial fibrillation among younger adults.
David Mataix-Cols, PhD; Suvi Virtanen, PhD; Anna Sidorchuk, MD, PhD; et al.
open access
JAMA Neurol. 2022;79(5):459-467. doi:10.1001/jamaneurol.2022.0167
This cohort study investigates whether Tourette syndrome or chronic tic disorder are associated with an increased risk of experiencing violent assault and criminal convictions.
Stefan Pszczolkowski, PhD; Nikola Sprigg, DM; Lisa J. Woodhouse, MSc; et al.
JAMA Neurol. 2022;79(5):468-477. doi:10.1001/jamaneurol.2022.0217
This substudy of a randomized clinical trial examines the association between use of a hemostatic agent and cerebral ischemic events in individuals who experienced acute intracerebral hemorrhage.
Eric L. Ross, MD; Marc S. Weinberg, MD, PhD; Steven E. Arnold, MD
JAMA Neurol. 2022;79(5):478-487. doi:10.1001/jamaneurol.2022.0315
This decision analytical model study evaluates the cost-effectiveness of aducanumab and donanemab for treatment of early Alzheimer disease in the US and estimates prices at which these agents would become cost-effective.
Kartik D. Bhatia, MBBS, PhD; Romain Briest, MBBS; Robert Goetti, MBBS; et al.
JAMA Neurol. 2022;79(5):488-497. doi:10.1001/jamaneurol.2022.0323
This cohort study investigates the incidence and natural history of pediatric large vessel occlusion stroke.
Jun Y. Oh, BA; Christine M. Walsh, PhD; Kamalini Ranasinghe, MBBS, PhD; et al.
JAMA Neurol. 2022;79(5):498-508. doi:10.1001/jamaneurol.2022.0429
This cohort study examines the correlation between the number of subcortical wake-promoting neurons and clinical sleep phenotypes in patients with Alzheimer disease and progressive supranuclear palsy.
Yu-Hui Liu, MD, PhD; Yang Chen, MD; Qing-Hua Wang, MD, PhD; et al.
free access
has active quiz
JAMA Neurol. 2022;79(5):509-517. doi:10.1001/jamaneurol.2022.0461
This cohort study evaluates cognitive functioning and decline in elderly COVID-19 survivors in China over a period of 12 months postinfection.
John J. Chen, MD, PhD; Saif Huda, MD, DPhil; Yael Hacohen, MD, DPhil; et al.
JAMA Neurol. 2022;79(5):518-525. doi:10.1001/jamaneurol.2022.0489
This cohort study assesses whether intravenous immunoglobulin therapy is associated with the prevention of relapses in adult patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD).